We can’t show the full text here under this license. Use the link below to read it at the source.
Effects of GLP-1RA Treatment on Long-Term Post-PCI Prognosis in T2DM Patients: A Propensity Score Matching Study
Long-Term Outcomes After Heart Procedure in Type 2 Diabetes Patients Treated with GLP-1 Receptor Agonists
AI simplified
Abstract
A total of 981 patients were enrolled, with 93 experiencing adverse cardiovascular events after 24 months of follow-up.
- Patients treated with (GLP-1RAs) had lower total cholesterol, LDL cholesterol, and HbA1c levels compared to those not treated with GLP-1RAs.
- The event-free survival rate was greater in the GLP-1RA group than in the control group, as indicated by survival curves.
- Factors such as body mass index (BMI), HDL cholesterol levels, and GLP-1RA use were identified as independent risk factors for (MACE) in patients after PCI.
- GLP-1RA treatment may be associated with improved long-term cardiovascular outcomes in type 2 diabetes patients following PCI.
AI simplified
Key numbers
0.617
Decrease in Risk
Hazard Ratio from multivariate Cox regression analysis.
93
Rate Improvement
Total number of in the matched cohort of 554 patients.
24 months
Follow-Up Duration
Duration of patient follow-up after .